| Style | Citing Format |
|---|---|
| MLA | Najafi S, et al.. "The Comparison of Anthracyclinebased and Non-Anthracycline-Based Regimens in Adjuvant Chemotherapy of Her2-Positive Non-Metastatic Breast Cancers." Wspolczesna Onkologia, vol. 22, no. 2, 2018, pp. 108-112. |
| APA | Najafi S, Sadeghi M, Shajari MR, Abasvandi F, Mohebi K (2018). The Comparison of Anthracyclinebased and Non-Anthracycline-Based Regimens in Adjuvant Chemotherapy of Her2-Positive Non-Metastatic Breast Cancers. Wspolczesna Onkologia, 22(2), 108-112. |
| Chicago | Najafi S, Sadeghi M, Shajari MR, Abasvandi F, Mohebi K. "The Comparison of Anthracyclinebased and Non-Anthracycline-Based Regimens in Adjuvant Chemotherapy of Her2-Positive Non-Metastatic Breast Cancers." Wspolczesna Onkologia 22, no. 2 (2018): 108-112. |
| Harvard | Najafi S et al. (2018) 'The Comparison of Anthracyclinebased and Non-Anthracycline-Based Regimens in Adjuvant Chemotherapy of Her2-Positive Non-Metastatic Breast Cancers', Wspolczesna Onkologia, 22(2), pp. 108-112. |
| Vancouver | Najafi S, Sadeghi M, Shajari MR, Abasvandi F, Mohebi K. The Comparison of Anthracyclinebased and Non-Anthracycline-Based Regimens in Adjuvant Chemotherapy of Her2-Positive Non-Metastatic Breast Cancers. Wspolczesna Onkologia. 2018;22(2):108-112. |
| BibTex | @article{ author = {Najafi S and Sadeghi M and Shajari MR and Abasvandi F and Mohebi K}, title = {The Comparison of Anthracyclinebased and Non-Anthracycline-Based Regimens in Adjuvant Chemotherapy of Her2-Positive Non-Metastatic Breast Cancers}, journal = {Wspolczesna Onkologia}, volume = {22}, number = {2}, pages = {108-112}, year = {2018} } |
| RIS | TY - JOUR AU - Najafi S AU - Sadeghi M AU - Shajari MR AU - Abasvandi F AU - Mohebi K TI - The Comparison of Anthracyclinebased and Non-Anthracycline-Based Regimens in Adjuvant Chemotherapy of Her2-Positive Non-Metastatic Breast Cancers JO - Wspolczesna Onkologia VL - 22 IS - 2 SP - 108 EP - 112 PY - 2018 ER - |